Concepedia

Esther C. Y. Lee

EC

Statistics

Publications

3

Citations

115

H-Index

3

Active since

2021

Affiliations

Pfizer (United States)(Current)

Esther C. Y. Lee is an author at Pfizer (United States) specializing in drug discovery, drug design, and medicinal chemistry.

ORCID

Publications per year

2021–2022

3

Publications

3

Bispecific Estrogen Receptor α Degraders Incorporating Novel Binders Identified Using DNA-Encoded Chemical Library Screening

Jeremy S. Disch, Jennifer M. Duffy, Esther C. Y. Lee et al. · Journal of Medicinal Chemistry · 2021 · 71 citations · Full text

, , +16

Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis

Kentaro Futatsugi, Shawn Cabral, Daniel W. Kung et al. · Journal of Medicinal Chemistry · 2022 · 28 citations

, , +13

Discovery of Novel, Potent Inhibitors of Hydroxy Acid Oxidase 1 (HAO1) Using DNA-Encoded Chemical Library Screening

Esther C. Y. Lee, Andrew J. McRiner, Katy E. Georgiadis et al. · Journal of Medicinal Chemistry · 2021 · 16 citations · Full text

, , +17

1–3 of 3